Viewing Study NCT06253533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-01-26 @ 8:32 PM
Study NCT ID: NCT06253533
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-02
First Post: 2024-01-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: ICVAX as a HIV Therapeutic DNA Vaccine
Sponsor: Immuno Cure Holding (HK) Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Immunodeficiency Virus View
None Human Immunodeficiency Virus I Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ICVAX View
None HIV View
None AIDS View
None DNA Vaccine View